Authors



Carol Graham

Latest:

Boosting Brain Health After COVID-19: A Convergence Solution

How can we face the current pandemic while addressing the brain health crisis?


Sri Gopal, MD

Latest:

The Best Solution to Nonadherence

More than 50% of patients with schizophrenia are estimated to be nonadherent with their antipsychotic medication regimen. What treatment solutions are available?


Raquel Gaerlan

Latest:

Sleep Spindles: A Comparison in Young Patients with Schizophrenia and Anti-NMDAR Encephalitis

What can we learn from sleep in schizophrenia? New research sheds light.


Anthony Scaramucci

Latest:

Defeating the Pandemic: The Necessity of Vaccination Mandates

Our country’s mental health depends on defeating this pandemic. The key to victory? Vaccine mandates.


Maria Tocco, MD

Latest:

Eating Disorder Exploitation in Entertainment: Helping the Artists and Their Fans

Many artists who have struggled with an eating disorder are generating content that is promoted by the entertainment industry, and when these conditions go unaddressed, the content has the potential to influence consumers.


Deepti A. Chopra, MBBS

Latest:

Serotonin Reuptake Inhibitor and Bleeding Risk, Part 2: Gastrointestinal (GI) Bleeding, Malignancy, Pregnancy, and Surgical Considerations

In this CME article, review literature on SRI-related bleeding complications in patients with GI bleeding, malignancy, perioperative settings, pregnancy, and hormonal therapy.


Shivan Bhavnani, CAIA

Latest:

Barriers to Digital Therapeutics Adoption

Digital therapeutics require adoption from 3 groups: psychiatrists, payers, and patients. What needs to be done to get everyone aboard?


Kimberly Van Orden, PhD

Latest:

Psychiatry for Primary Care: Suicide Risk Assessment and Prevention (Part 3)

In the absence of definitive data, how can primary care providers help prevent suicide and provide compassionate care that promotes quality of life in their patients?


Barry Blackwell, MD

Latest:

An Introduction to Treating the Brain: An Odyssey

The history of modern psychopharmacology: a history of epic proportions.


Scot G. McAfee, MD

Latest:

Psychiatrists Call for End to Cruel and Harmful Immigration Policy

The Group for the Advancement of Psychiatry (America’s mental health think tank) calls for an end to the use of Title 42 to expel asylum seekers at the southern border. This policy places LGBTIQ asylum seekers in particular danger.


Lediya Dumessa, PhD

Latest:

Mental Health as a Role in Mortality Rates in Peri- and Postpartum Black Women

Black mothers in the US experience far worse outcomes. Here’s what clinicians need to know.



Mary Kate Keyes, MS, RDN

Latest:

3 Positives and Negatives to Nourish Your Mental Health

Mental health support is only as good as the foundation upon which it is built.


Ian Robertson, PhD

Latest:

Brain Capital: An Emerging Investment Opportunity

Brain Capital: a fresh approach to technologies and investing.


Horacio A. Capote, MD

Latest:

Exploring the New Era of Hope and Possibilities for Patients With Dementia

"To be sure, we are still in the nascent stages of developing treatments. However, our armamentarium is steadily growing."


Nick Thomarios, DO, MBA, FAPA

Latest:

Developing Your Skills at the Intersection of Work and Psychiatry

Here’s how the Academy of Organizational and Occupational Psychiatry can help you connect with your fellow psychiatrists about complex mental health issues in the workplace.


Dave R. Praharaj

Latest:

What to Expect When Your Patients With ADHD Are Expecting

A new study provides guidance for clinicians discussing the risks of ADHD medications with their pregnant patients.


Paul Fitzgerald, MD, PhD

Latest:

Curing Stubborn Depression: Educating Patients and the Public

How can we offer options and hope for the future to patients with treatment-resistant depression?


Sarah H. Arshad, MD

Latest:

Why Psychiatry Training Must Include Discussions on Structural Racism

The authors explore the impact of structural racism on psychiatry trainees and the patients they care for (and what can be done about it).


George Perry, PhD

Latest:

A Skeptical Look at Aducanumab

The FDA approval of aducanumab has given hope to millions of patients with Alzheimer disease—but will it live up to the hype?


Jessica Lyons, MS, LMFT

Latest:

Unique Collaborative Care System: Solution to the Youth Mental Health Crisis

Integrated models of care offer real time solutions by enabling primary care to identify and address behavioral health concerns through routine screening and early intervention more efficiently. Learn more here.


John Kraus, MD, PhD

Latest:

Rejoyn: A Fundamental Change in How Clinicians Can Treat MDD Symptoms

Rejoyn was recently cleared by the FDA, making it the first prescription digital therapeutic for major depressive disorder.


Paul Noufi, MD

Latest:

The Final “P” in Pain Management

With a broader and multifaceted understanding of pain, patient care can move from a focus on eradicating pain, as based on objective pain scores, to improving the patient’s quality of life, while simultaneously decreasing pain to a level that is acceptable to the individual patient.


Syed Iqbal, MD

Latest:

Breaking the Spell: Fighting Myths About COVID-19 Vaccination

The vaccine needs to be appropriately framed: as a benefit, not a risk.


Lyons Hardy, MS, PMHNP, RN

Latest:

Thinking Beyond the Guidelines: Evidence-Based Novel Therapies for Bipolar Depression

In this CME article, learn how to apply novel treatment approaches for patients with bipolar depression.


Megan Ehret, PharmD, MS

Latest:

REMS for Psychiatric Medications: The Good, the Bad, and the Ugly

Session at the 2023 American Psychiatric Association Annual Meeting shares insights on REMS for psychiatric medications.


Crystal Han, MD

Latest:

It’s Not Easy Being Yellow

“There are things that I think an Asian therapist would just understand… Maybe with them I can just be a normal person.”


Jiahui Li

Latest:

Connections Between Food Additives and Psychiatric Disorders

What are the connections between what we eat and disorders such as anxiety and depression?


Elizabeth LaSalvia, MD

Latest:

Developing a Collaborative Approach to Post-Acute Sequelae of SARS-CoV-2 Infection

1 in 3 COVID-19 survivors experience persistent consequences. What can psychiatry do to help?

© 2024 MJH Life Sciences

All rights reserved.